News
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
We spoke with Josh Hoerner, general manager of Purisys, which specializes in a small volume custom synthesis and specialized ...
Leos is supported by emerging data from a randomized controlled clinical trial, further validating its safety and efficacy.
Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM) explains the differences between bexagliflozin and velagliflozin, and how to determine if a patient is a good candidate ...
Discretionary spending by HHS is the major target of cuts in a preliminary budget from the Trump administration obtained by ...
Patients walk in primed with information from an Internet search and want an official answer. Three experts tackle the questions they hear most.
This is the first of a series on Representative Thomas Romeo Quioh’s involvement with a Sinoe County community forest contract. NUMOPOH – Sinoe County Representative Thomas Romeo Quioh allegedly ...
One of the co-founders of Elon Musk’s Neuralink Corp. is building a different kind of brain implant. That device, made by the startup Precision Neuroscience Corp., went in 63-year-old Tim Fisher ...
To help bring down sky-high drug prices, President Donald Trump signed an executive order pushing for faster biosimilar ...
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
FDA Drug Inspections Post–Workforce Reductions: Potential Implications and Practical Steps Forward
The US Food and Drug Administration (FDA) is confronted with significant challenges in its inspection processes due to recent layoffs. Among ...
Robert F. Kennedy Jr.'s decision to appoint David Geier, a figure previously disciplined for administering puberty-blocking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results